Author(s) |
(Date) |
Paper Title |
Citation |
Model Type |
Applications |
Full Text |
| Arieta CM, et al. Mouse over for full list |
(2023) | The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. | Cell 186(11):2392-2409.e21 | Vaccine Research | ||
| Carter B, et al. Mouse over for full list |
(2023) | A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. | Front Immunol 14:1135815 | Infectious Disease, Vaccine Research | ||
| Peng S, et al. Mouse over for full list |
(2022) | Identification of human MHC-I HPV18 E6/E7-specific CD8?+?T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice. | J Biomed Sci 29(1):80 | Infectious Disease, Vaccine Research | ||
| Quach HQ, et al. Mouse over for full list |
(2022) | Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine. | Sci Rep 12(1):15401 | Infectious Disease, Vaccine Research | ||
| Chyu KY, et al. Mouse over for full list |
(2022) | Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis. | JCI Insight 7(11) | Vaccine Research | ||
| Vardeu A, et al. Mouse over for full list |
(2022) | Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses. | J Immunother Cancer 10(11) | Vaccine Research, Immuno-Oncology | ||
| Isakova-Sivak I, et al. Mouse over for full list |
(2022) | Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector. | Vaccines (Basel) 10(7) | Infectious Disease, Vaccine Research | ||
| Wentworth PA, et al. Mouse over for full list |
(1996) | Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. | Eur J Immunol 26(1):97-101 | Immunology, T And/Or B Cell Function | ||
| Chitlaru T, et al. Mouse over for full list |
(2021) | Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 Infection. | Pathogens 10(8) | |||
| Ji J, et al. Mouse over for full list |
(2014) | Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. | Stem Cells Transl Med 3(3):356-64 | Infectious Disease, Vaccine Research | ||
| Kotturi MF, et al. Mouse over for full list |
(2009) | A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease. | PLoS Pathog. 5(12):e1000695 | Infectious Disease, Vaccine Research | ||
| Singh RA, et al. Mouse over for full list |
(2003) | Generation of multivalent genome-wide T cell responses in HLA-A*0201 transgenic mice by an HIV-1 expression library immunization (ELI) vaccine. | Res Initiat Treat Action 8(2):17-9 | Infectious Disease, HIV, Vaccine Research | ||
| Singh RA, et al. Mouse over for full list |
(2002) | Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. | J. Immunol. 168(1):379-91 | Infectious Disease, HIV, Vaccine Research | ||
| Pasquetto V, et al. Mouse over for full list |
(2005) | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. | J. Immunol. 175(8):5504-15 | Infectious Disease | ||
| Nanjundappa RH, et al. Mouse over for full list |
(2012) | Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. | Vaccine 30(24):3519-25 | Vaccine Research | ||
| Kang YJ, et al. Mouse over for full list |
(2013) | Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DO? as a novel target for multiple myeloma. | Br. J. Haematol. 163(3):343-51 | Oncology, Myeloma, Vaccine Research | ||
| Casnici C, et al. Mouse over for full list |
(2012) | Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice. | J. Immunother. 35(4):321-8 | Oncology, Vaccine Research | ||
| Botten J, et al. Mouse over for full list |
(2006) | Identification of protective Lassa virus epitopes that are restricted by HLA-A2. | J. Virol. 80(17):8351-61 | Infectious Disease, Vaccine Research | ||
| Yoshida M, et al. Mouse over for full list |
(2017) | Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency. | Sci Rep 7(1):11137 | Vaccine Research | ||
| Testa JS, et al. Mouse over for full list |
(2012) | MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. | PLoS ONE 7(11):e48484 | Infectious Disease, Vaccine Research | ||
| Zhai MX, et al. Mouse over for full list |
(2015) | Novel epitopes identified from efflux pumps of Mycobacterium tuberculosis could induce cytotoxic T lymphocyte response. | PeerJ 3:e1229 | Infectious Disease, Tuberculosis | ||
| Weiskopf D, et al. Mouse over for full list |
(2011) | Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. | J. Immunol. 187(8):4268-79 | Infectious Disease, Dengue, Vaccine Research | ||
| Wilson CC, et al. Mouse over for full list |
(2003) | Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. | J. Immunol. 171(10):5611-23 | Infectious Disease, HIV, Vaccine Research | ||
| Vitiello A, et al. Mouse over for full list |
(1991) | Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. | J. Exp. Med. 173(4):1007-15 | Infectious Disease | ||
| Tseng-Rogenski SS, et al. Mouse over for full list |
(2009) | A safety-modified SV40 Tag developed for human cancer immunotherapy. | Drug Des Devel Ther 2:17-24 | Oncology, Vaccine Research, Immuno-Oncology | ||
| Seavey MM, et al. Mouse over for full list |
(2009) | A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors. | Clin. Cancer Res. 15(3):924-32 | Oncology, Immuno-Oncology | ||
| Oseroff C, et al. Mouse over for full list |
(1998) | Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses. | Vaccine 16(8):823-33 | Infectious Disease, Hepatitis-B, Hepatitis-C, Vaccine Research | ||
| McKinney DM, et al. Mouse over for full list |
(2004) | Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL. | J. Immunol. 173(3):1941-50 | HIV, Vaccine Research | ||
| Men Y, et al. Mouse over for full list |
(1999) | Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. | J. Immunol. 162(6):3566-73 | Vaccine Research | ||
| Dubey JP, et al. Mouse over for full list |
(2012) | Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. | Parasitology 139(1):1-13 | Infectious Disease | ||
| Depla E, et al. Mouse over for full list |
(2008) | Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. | J. Virol. 82(1):435-50 | Hepatitis-B, Vaccine Research | ||
| Cong H, et al. Mouse over for full list |
(2011) | Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. | Vaccine 29(4):754-62 | Infectious Disease, Vaccine Research | ||
| Botten J, et al. Mouse over for full list |
(2010) | A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans. | J. Virol. 84(19):9947-56 | Infectious Disease, Vaccine Research | ||
| Botten J, et al. Mouse over for full list |
(2007) | HLA-A2-restricted protection against lethal lymphocytic choriomeningitis. | J. Virol. 81(5):2307-17 | Infectious Disease, Vaccine Research | ||
| Alexander J, et al. Mouse over for full list |
(2002) | A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. | J. Immunol. 168(12):6189-98 | Vaccine Research |
Welcome! Tell us a little about yourself